Skip to main content
. 2014 Jun 2;32(20):2142–2150. doi: 10.1200/JCO.2013.53.1608

Table A4.

DRFS of Patients With HR-Positive/HER2-Negative T1a,bN0 Breast Cancer by Histologic Grade, NCCN 2000-2009

DRFS Grade No Chemotherapy
Chemotherapy
No. of Patients 5-Year Estimate (%) 95% CI No. of Patients 5-Year Estimate (%) 95% CI
Low-intermediate 2,485 97 96 to 97 156 95 90 to 98
High 434 94 91 to 96 92 98 91 to 99

Abbreviations: DRFS, distant relapse-free survival; HER2, human epidermal growth factor receptor 2; HR, hormone receptor; NCCN, National Comprehensive Cancer Network.